Target intelligence / Profile preview

RNA, U1 small nuclear 5, pseudogene (RNU1-5P)

Target
RNU1-5P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNA, U1 small nuclear 5, pseudogene (RNU1-5P) is a pseudogene that corresponds to the U1 small nuclear RNA (snRNA) gene family, specifically a non-functional copy of the U1 snRNA gene[1][3]. U1 snRNA itself is a critical component of the U1 small nuclear ribonucleoprotein complex, which is essential for pre-mRNA splicing in the spliceosome[2][4]. However, pseudogenes such as RNU1-5P are typically not transcribed into functional RNA or protein products and are considered genomic relics with no known direct biological or therapeutic role[1][3]. RNU1-5P does not encode a receptor, enzyme, or any protein, and it is not considered a therapeutic target. The presence of "pseudogene" in its name, and confirmation from genetic databases, indicates that this locus does not produce active or functional RNA with a characterized biological function[1][3]. Some U1 snRNA pseudogenes may be transcribed at very low levels or contribute to regulatory non-coding RNA pools, but there is no evidence for such a role for RNU1-5P at this time. Notes: - This entry is likely incorrect as a therapeutic target since pseudogenes are not drug targets and this specific pseudogene lacks known function or role in disease[1][3]. - The confusion may arise from conflating the functional U1 snRNA genes (which play key roles in splicing) with non-functional pseudogenes like RNU1-5P. - The correct molecular classification is pseudogene, which falls under "other" or "non-coding RNA" categories, not a receptor, enzyme, or classic drug target.

Other names
RNU1-5RNU1-5P
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, not known to have a biological function)The parental U1 small nuclear RNA is involved in pre-mRNA splicing
04

Disease associations

None established for this pseudogene (the parental U1 snRNA and its processing pathway are implicated in some neurological diseases, but not the pseudogene itself)

Beyond the preview

Go deeper on RNA, U1 small nuclear 5, pseudogene (RNU1-5P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 5, pseudogene (RNU1-5P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call